Lipophilic describes a molecule or a region of one that partitions preferentially into a lipid phase rather than water, conventionally quantified as logP. In peptides, lipophilicity is carried by specific side chains — phenylalanine, tryptophan, leucine, isoleucine, valine and methionine — and by any attached fatty acid or lipid tail.
Why lipophilicity matters in peptide research
Three consequences follow. First, solubility: a sequence rich in lipophilic residues resists dissolving in plain aqueous buffer and may need a small volume of organic co-solvent before dilution, which is a common cause of a vial that appears not to reconstitute. Second, aggregation: exposed lipophilic patches drive peptides to associate with one another, producing cloudiness or fibrils that a nominal purity figure will not predict. Third, engineered lipophilicity is a design tool — the C18 fatty di-acid on semaglutide and the C16 chain on liraglutide exist to bind serum albumin and extend half-life, the same objective pursued differently by DAC and PEGylation.
Lipophilicity also interacts with charge: near a peptide’s isoelectric point the molecule carries no net charge, and hydrophobic association dominates. Practical handling is set out in the peptide solubility guide.